Some Good Covid Reads
Is Big Pharma behind the great war on hydroxychloroquine?
And what's behind the touting of Remdesivir?
Is it really about the money, as one commenter stated?
James Todaro has some strong views on that:
Remember in 2014 when Gilead won FDA approval for the drug Harvoni? The price per patient was $94,500 if you wanted your Hepatitis C cured.
Gilead isn’t a charity.
May 4
Gilead receives $37.5M grant to develop/test Remdesivir—courtesy of US taxpayers
Taxpayer funded study shows small non-mortality benefit...FDA approves Remdesivir
Patient cost: $1000
Remdesivir manufacture cost: $10
Gilead projected 2020 revenue for Remdesivir: $1,000,000,000
Washington (Kirkland) nursing home: No hydroxychloroquine, 35 deaths out of 120 residents
Texas nursing home: Treatment WITH hydroxychloroquine, 1 death out of 135 residents
#COVIDー19 #coronavirus
The NIH Panel on COVID-19 Treatment Guidelines is made up of 50 researchers & physicians.
This panel will decide treatment recommendations for Remdesivir.
Nearly 20% of this panel is employed by or has investment interests in Gilead.